Evidence map›Paper›PMID 30487282›Full record

ArticleJournal of virology2019

Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.

Fabrizio Angius, Heidi Smuts, Ksenia Rybkina, Debora Stelitano, Brian Eley, Jo Wilmshurst, Marion Ferren, Alexandre Lalande, Cyrille Mathieu, Anne Moscona and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Unraveling the complexities of neurotropic virus infection and immune evasion.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antiviral activity of nitazoxanide againstJournal of virus eradication · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 5 countries.

Fabrizio Angius *Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Heidi Smuts *Division of Medical Virology, Department of Pathology, University of Cape Town and National Health Laboratory Service, Cape Town, South Africa.
Ksenia Rybkina *Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Debora StelitanoCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Brian EleyPaediatric Infectious Diseases Unit, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Jo WilmshurstPaediatric Neurology Unit, Red Cross War Memorial Children's Hospital, Cape Town, South Africa.
Marion FerrenCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Alexandre LalandeCIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.
Cyrille MathieuCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Anne MosconaCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA.
Branka HorvatCIRI, International Center for Infectiology Research, Inserm, U1111, University Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Lyon, France.ORCID 0000-0003-0578-7765
Takao HashiguchiDepartment of Virology, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Matteo PorottoCenter for Host-Pathogen Interaction, Columbia University Medical Center, New York, New York, USA mp3509@columbia.edu diana.hardie@uct.ac.za.
Diana HardieDivision of Medical Virology, Department of Pathology, University of Cape Town and National Health Laboratory Service, Cape Town, South Africa mp3509@columbia.edu diana.hardie@uct.ac.za.
Columbia University Irving Medical Center · USNational Health Laboratory Service · ZAUniversité Claude Bernard Lyon 1 · FRUniversity of Cape Town · ZAKyushu University · JPUniversity of Campania "Luigi Vanvitelli" · IT

Funding

Mechanisms of measles virus CNS adaptationR01NS091263 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI POROTTO, MATTEO · 2015 to 2019
$1.9M
Development of therapeutic fusion inhibitor peptides for Measles encephalitisR01NS105699 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI POROTTO, MATTEO · 2018 to 2022
$1.8M
NINDS NIH HHS R01 NS091263NINDS NIH HHS R01 NS105699
6 · The paper itself

Abstract

During a measles virus (MeV) epidemic in 2009 in South Africa, measles inclusion body encephalitis (MIBE) was identified in several HIV-infected patients. Years later, children are presenting with subacute sclerosing panencephalitis (SSPE). To investigate the features of established MeV neuronal infections, viral sequences were analyzed from brain tissue samples of a single SSPE case and compared with MIBE sequences previously obtained from patients infected during the same epidemic. Both the SSPE and the MIBE viruses had amino acid substitutions in the ectodomain of the F protein that confer enhanced fusion properties. Functional analysis of the fusion complexes confirmed that both MIBE and SSPE F protein mutations promoted fusion with less dependence on interaction by the viral receptor-binding protein with known MeV receptors. While the SSPE F required the presence of a homotypic attachment protein, MeV H, in order to fuse, MIBE F did not. Both F proteins had decreased thermal stability compared to that of the corresponding wild-type F protein. Finally, recombinant viruses expressing MIBE or SSPE fusion complexes spread in the absence of known MeV receptors, with MIBE F-bearing viruses causing large syncytia in these cells. Our results suggest that alterations to the MeV fusion complex that promote fusion and cell-to-cell spread in the absence of known MeV receptors is a key property for infection of the brain.

Indexed as

Amino Acid SubstitutionAnimalsBrainCell Adhesion MoleculesChlorocebus aethiopsEpidemicsFemaleGenotypeGiant CellsHEK293 CellsHumansMaleMeaslesMeasles virusMutationNeuronsCell Adhesion MoleculesViral Fusion Proteinscentral nervous system infectionsmeaslesviral fusion

Identifiers

PMID30487282
PMCPMC6364028
OpenAlexW2903111595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.